Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Aspertame Link to Cancer Rejected by FDA, as World Health Org Labels Sweetener a Possible Carcinogen WHO is not recommending any changes to acceptable daily limits of aspartame, despite the potential cancer risks, which FDA and other industry experts have rejected July 17, 2023 Irvin Jackson Add Your Comments Amid growing concerns about the side effects of artificial sweeteners commonly used in a number of products, the World Health Organization (WHO) has officially declared that aspartame is a “possible carcinogen”. However, U.S. food regulators immediately noted that they disagree with that assessment. WHO issued the long-anticipated assessment of the aspartame link to cancer last week, confirming that the organization believes the sweetener may be carcinogenic to humans, even though the risk is low. The decision is reportedly based on a comprehensive review of scientific research conducted by the International Agency for Research on Cancer (IARC), the WHO’s cancer research division. Food industry executives have immediately criticized the decision to link aspertame to cancer, indicating that it is generally safe to ingest in limited amounts found in consumer products. However, various studies have highlighted the connection between aspartame and cancer, even at low consumption levels. The food industry has long marketed artificial sweeteners like aspartame as not only safe, but also beneficial for health goals like weight loss. But the WHO recently determined that using artificial sweeteners for long term weight loss is ineffective for most people. The group recommended natural sugar intake reduction for slimming, instead of using artificial sweeteners linked to increased risk of heart disease, diabetes, and high blood pressure, in addition to cancer. Do You Know about… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION FDA Challenges WHO Aspartame Cancer Label In its assessment, the WHO’s Joint Expert Committee on Food Additives (JECFA) determined that there is no reason to change the previously established acceptable daily intake (ADI) of aspartame from its current 0-40 mg per kilogram of body weight. As an example, it would take consuming nine to 14 cans of diet soda sweetened with aspartame to exceed that limit. However, the decision to classify aspartame as a possible carcinogen is still receiving pushback. In a statement issued on July 14, the U.S. Food and Drug Administration (FDA) indicates that it disagrees with WHO’s findings, noting that aspartame is one of the most studied food additives in the human food sully, and that it’s scientists do not think there are safety concerns when aspartame is used as approved. “The FDA disagrees with IARC’s conclusion that these studies support classifying aspartame as a possible carcinogen to humans. FDA scientists reviewed the scientific information included in IARC’s review in 2021 when it was first made available and identified significant shortcomings in the studies on which IARC relied,” the FDA statement determines. “We note that JECFA did not raise safety concerns for aspartame under the current levels of use and did not change the Acceptable Daily Intake.” Artificial Sweetener Side Effects Health concerns over the widespread use of artificial sweeteners have spiked over the past year, following a number of studies that suggest side effects may damage DNA, increase the risk of cancer, heart disease or other health conditions. In late May, a study published in the Journal of Toxicology and Environmental Health warned that the artificial sweetener Splenda (sucralose-6-acetate) could be linked to an increased risk of DNA damage, which could lead to serious side effects, including cancer and several other diseases. Genotoxic testing and micronucleus testing both indicated sucralose damages the genes in the body. The research also concluded it is clastogenic, which means it leads to breaks in the DNA strand. A study published in the journal PLOS Medicine in 2022 also concluded consuming artificial sweeteners like Splenda, Equal, and Sweet One increases a person’s risk of cancer by 13 to 22%, particularly breast cancer, prostate cancer, and obesity-related cancers. Intestinal permeability can also heighten inflammation and lead to bloating, cramps, Crohn’s disease, and other gastrointestinal conditions. In addition, new researcher published earlier this month suggests that widely used artificial sweeteners, such as NutraSweet, Equal, Stevia, Splenda and others, may actually cause a person to gain weight, instead of lose it, and increase their risk for type 2 diabetes, high blood pressure, heart disease and other health issues. Despite disagreeing with WHO’s assessment for aspartame, the FDA indicates it will continue to monitor emerging science on aspartame and other sweeteners, amid growing public concerns about their safety. Tags: Artificial Sweetener, Aspartame, Cancer, Food Additive More Lawsuit Stories Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials April 2, 2025 Nitrous Oxide Class Action Lawsuit Filed Over Fatal Side Effects of Flavored Gas Sold In Vape Shops April 2, 2025 Artificial Stone Cutter Files Lawsuit Over Silicosis Lung Disease April 2, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (Posted: today) As new BioZorb lawsuits continue to be filed over complications with the recalled breast tissue markers, lawyers indicate they are on track for the first of four test cases to go before a jury in September 2025. MORE ABOUT: BIOZORB LAWSUITCourt Clears BioZorb Lawsuit Design Defect Claims Over Recalled Breast Tissue Marker (03/26/2025)Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (03/19/2025)Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025) Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: yesterday) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025) Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: 2 days ago) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025)
Nitrous Oxide Class Action Lawsuit Filed Over Fatal Side Effects of Flavored Gas Sold In Vape Shops April 2, 2025
Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (Posted: today) As new BioZorb lawsuits continue to be filed over complications with the recalled breast tissue markers, lawyers indicate they are on track for the first of four test cases to go before a jury in September 2025. MORE ABOUT: BIOZORB LAWSUITCourt Clears BioZorb Lawsuit Design Defect Claims Over Recalled Breast Tissue Marker (03/26/2025)Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (03/19/2025)Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025)
Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: yesterday) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)
Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: 2 days ago) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025)